...
search icon
avtx-img

Avalo Therapeutics Inc Share Price

AVTX
NAQ
$14.855
-$1.12
(-7.01%)
1D
Industry: Biotechnology Sector: Health Care

Avalo Therapeutics Inc Analyst Forecast

Avalo Therapeutics Inc Share Price Chart

Avalo Therapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$295.65M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
27.09K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.89
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.39 L
$20.72 H
$14.855

About Avalo Therapeutics Inc, Common Stock

Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. Its lead asset includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland. more

Industry: BiotechnologySector: Health Care

Avalo Therapeutics Inc Stock Returns

Time FrameAVTXSectorS&P500
1-Week Return10.9%0.81%0.49%
1-Month Return7.91%1.2%1.02%
3-Month Return-9.21%3.24%3.34%
6-Month Return79.54%14.99%7.04%
1-Year Return128.47%7.42%11.68%
3-Year Return-97.95%20.71%71.63%
5-Year Return-99.87%37.45%75.56%
10-Year Return-99.82%138.53%257.55%

Avalo Therapeutics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue6.70M5.40M18.05M1.92M441.00K[{"date":"2020-12-31","value":37.11,"profit":true},{"date":"2021-12-31","value":29.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":10.66,"profit":true},{"date":"2024-12-31","value":2.44,"profit":true}]
Cost of Revenue300.00K1.49M3.43M1.28M(366.00K)[{"date":"2020-12-31","value":8.74,"profit":true},{"date":"2021-12-31","value":43.42,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":37.39,"profit":true},{"date":"2024-12-31","value":-10.66,"profit":false}]
Gross Profit6.40M3.91M14.62M640.00K807.00K[{"date":"2020-12-31","value":43.78,"profit":true},{"date":"2021-12-31","value":26.73,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":4.38,"profit":true},{"date":"2024-12-31","value":5.52,"profit":true}]
Gross Margin95.52%72.38%80.98%33.26%182.99%[{"date":"2020-12-31","value":52.2,"profit":true},{"date":"2021-12-31","value":39.55,"profit":true},{"date":"2022-12-31","value":44.25,"profit":true},{"date":"2023-12-31","value":18.18,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses6.40M86.04M52.06M27.99M69.32M[{"date":"2020-12-31","value":7.44,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":60.5,"profit":true},{"date":"2023-12-31","value":32.53,"profit":true},{"date":"2024-12-31","value":80.57,"profit":true}]
Operating Income(26.95M)(82.13M)(37.44M)(27.35M)(68.51M)[{"date":"2020-12-31","value":-2695300000,"profit":false},{"date":"2021-12-31","value":-8213400000,"profit":false},{"date":"2022-12-31","value":-3744000000,"profit":false},{"date":"2023-12-31","value":-2735100000,"profit":false},{"date":"2024-12-31","value":-6851200000,"profit":false}]
Total Non-Operating Income/Expense(67.13M)(4.80M)(8.36M)(8.63M)36.81M[{"date":"2020-12-31","value":-182.34,"profit":false},{"date":"2021-12-31","value":-13.04,"profit":false},{"date":"2022-12-31","value":-22.71,"profit":false},{"date":"2023-12-31","value":-23.43,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(67.18M)(84.55M)(41.63M)(31.53M)(35.02M)[{"date":"2020-12-31","value":-6717700000,"profit":false},{"date":"2021-12-31","value":-8454500000,"profit":false},{"date":"2022-12-31","value":-4163000000,"profit":false},{"date":"2023-12-31","value":-3153000000,"profit":false},{"date":"2024-12-31","value":-3501500000,"profit":false}]
Income Taxes(2.79M)(196.00K)28.00K14.00K114.00K[{"date":"2020-12-31","value":-2450,"profit":false},{"date":"2021-12-31","value":-171.93,"profit":false},{"date":"2022-12-31","value":24.56,"profit":true},{"date":"2023-12-31","value":12.28,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(64.38M)(84.35M)(41.66M)(31.54M)(35.13M)[{"date":"2020-12-31","value":-6438400000,"profit":false},{"date":"2021-12-31","value":-8434900000,"profit":false},{"date":"2022-12-31","value":-4165800000,"profit":false},{"date":"2023-12-31","value":-3154400000,"profit":false},{"date":"2024-12-31","value":-3512900000,"profit":false}]
Income From Continuous Operations(64.38M)(84.35M)(41.66M)(33.19M)(35.13M)[{"date":"2020-12-31","value":-6438310100,"profit":false},{"date":"2021-12-31","value":-8434900000,"profit":false},{"date":"2022-12-31","value":-4165800000,"profit":false},{"date":"2023-12-31","value":-3318800000,"profit":false},{"date":"2024-12-31","value":-3512900000,"profit":false}]
Income From Discontinued Operations883.78K(27.00K)---[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-3.06,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(63.50M)(84.38M)(41.66M)(31.54M)(35.13M)[{"date":"2020-12-31","value":-6350000000,"profit":false},{"date":"2021-12-31","value":-8437600000,"profit":false},{"date":"2022-12-31","value":-4165800000,"profit":false},{"date":"2023-12-31","value":-3154400000,"profit":false},{"date":"2024-12-31","value":-3512900000,"profit":false}]
EPS (Diluted)(10.56)(9.96)(4.48)(117.76)(159.06)[{"date":"2020-12-31","value":-1056,"profit":false},{"date":"2021-12-31","value":-996,"profit":false},{"date":"2022-12-31","value":-448,"profit":false},{"date":"2023-12-31","value":-11776,"profit":false},{"date":"2024-12-31","value":-15906,"profit":false}]

Avalo Therapeutics Inc Ratios

Avalo Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

AVTX
Cash Ratio 14.00
Current Ratio 14.28

Avalo Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AVTX
ROA (LTM) -37.18%
ROE (LTM) -174.79%

Avalo Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AVTX
Debt Ratio Lower is generally better. Negative is bad. 0.27
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.73

Avalo Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AVTX
Trailing PE NM
Forward PE NM
P/S (TTM) 1446.31
P/B 2.88
Price/FCF NM
EV/R 795.55
EV/Ebitda NM

FAQs

What is Avalo Therapeutics Inc share price today?

Avalo Therapeutics Inc (AVTX) share price today is $14.855

Can Indians buy Avalo Therapeutics Inc shares?

Yes, Indians can buy shares of Avalo Therapeutics Inc (AVTX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AVTX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Avalo Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Avalo Therapeutics Inc (AVTX) via the Vested app. You can start investing in Avalo Therapeutics Inc (AVTX) with a minimum investment of $1.

How to invest in Avalo Therapeutics Inc shares from India?

You can invest in shares of Avalo Therapeutics Inc (AVTX) via Vested in three simple steps:

  • Click on Sign Up or Invest in AVTX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Avalo Therapeutics Inc shares
What is Avalo Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Avalo Therapeutics Inc (AVTX) is $20.72. The 52-week low price of Avalo Therapeutics Inc (AVTX) is $3.39.

What is Avalo Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Avalo Therapeutics Inc (AVTX) is

What is Avalo Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Avalo Therapeutics Inc (AVTX) is 2.88

What is Avalo Therapeutics Inc dividend yield?

The dividend yield of Avalo Therapeutics Inc (AVTX) is 0.00%

What is the Market Cap of Avalo Therapeutics Inc?

The market capitalization of Avalo Therapeutics Inc (AVTX) is $295.65M

What is Avalo Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Avalo Therapeutics Inc is AVTX

How Can Investors Use Avalo Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Avalo Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Avalo Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Avalo Therapeutics Inc shares for Indian investors?

When investing in Avalo Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Avalo Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Avalo Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Avalo Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Avalo Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top